APA (7th ed.) Citation

Xuezhi Zhuo, Maud Margrethe Brekstad Kjellin, Zarah Schaal, Tengyu Zhang, Korbinian Löbmann, & Donglei Leng. (2022). A Comparative Study between A Protein Based Amorphous Formulation and Other Dissolution Rate Enhancing Approaches: A Case Study with Rifaximin. MDPI AG.

Chicago Style (17th ed.) Citation

Xuezhi Zhuo, Maud Margrethe Brekstad Kjellin, Zarah Schaal, Tengyu Zhang, Korbinian Löbmann, and Donglei Leng. A Comparative Study Between A Protein Based Amorphous Formulation and Other Dissolution Rate Enhancing Approaches: A Case Study with Rifaximin. MDPI AG, 2022.

MLA (9th ed.) Citation

Xuezhi Zhuo, et al. A Comparative Study Between A Protein Based Amorphous Formulation and Other Dissolution Rate Enhancing Approaches: A Case Study with Rifaximin. MDPI AG, 2022.